These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 36627897)

  • 1. Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces.
    Safa AR
    Cancer Drug Resist; 2022; 5(4):850-872. PubMed ID: 36627897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to drugs and cell death in cancer stem cells (CSCs).
    Safa AR
    J Transl Sci; 2020 Jun; 6(3):. PubMed ID: 35330670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.
    Sastry KS; Chouchane AI; Wang E; Kulik G; Marincola FM; Chouchane L
    Cell Death Dis; 2017 Jun; 8(6):e2844. PubMed ID: 28569785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and Apoptosis.
    Chaudhry GE; Akim AM; Sung YY; Muhammad TST
    Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting resistant breast cancer stem cells in a three-dimensional culture model with oleuropein encapsulated in methacrylated alginate microparticles.
    Altundag-Erdogan O; Tutar R; Yüce E; Çelebi-Saltik B
    Daru; 2024 Dec; 32(2):471-483. PubMed ID: 38722566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2 in cancer stemness: tumor malignancy and therapeutic potentials.
    Mamun MA; Mannoor K; Cao J; Qadri F; Song X
    J Mol Cell Biol; 2020 Feb; 12(2):85-98. PubMed ID: 30517668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting redox regulation and autophagy systems in cancer stem cells.
    Khan SU; Rayees S; Sharma P; Malik F
    Clin Exp Med; 2023 Sep; 23(5):1405-1423. PubMed ID: 36473988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-FLIP, a master anti-apoptotic regulator.
    Safa AR
    Exp Oncol; 2012 Oct; 34(3):176-84. PubMed ID: 23070002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced efficacy of chemotherapy for breast cancer stem cells by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense.
    Sun M; Yang C; Zheng J; Wang M; Chen M; Le DQS; Kjems J; Bünger CE
    Acta Biomater; 2015 Dec; 28():171-182. PubMed ID: 26415776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy Regulation on Cancer Stem Cell Maintenance, Metastasis, and Therapy Resistance.
    Wang X; Lee J; Xie C
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salinomycin as a drug for targeting human cancer stem cells.
    Naujokat C; Steinhart R
    J Biomed Biotechnol; 2012; 2012():950658. PubMed ID: 23251084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
    Du FY; Zhou QF; Sun WJ; Chen GL
    World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapies targeting cancer stem cells: Current trends and future challenges.
    Dragu DL; Necula LG; Bleotu C; Diaconu CC; Chivu-Economescu M
    World J Stem Cells; 2015 Oct; 7(9):1185-201. PubMed ID: 26516409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.